@article{4abf1c8f026e48a7b3e77f2f340dace7,
title = "CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease",
keywords = "autoimmunity, chemokines, cytokines, disease activity",
author = "Mitsuhiro Akiyama and Hidekata Yasuoka and Keiko Yoshimoto and Tsutomu Takeuchi",
note = "Funding Information: Competing interests MA has received consultancies, speaking fees and honoraria from Asahi Kasei Co, Cure Grades Co, and Eisai Co., and a research grant from Mitsubishi Tanabe Pharma Co. TT has received consulting fees, speaking fees and/or honoraria from Pfizer Japan, Mitsubishi Tanabe Pharma, Eisai, Astellas Pharma and UCB (less than \$10 000 each) and Chugai Pharmaceutical, Bristol-Myers K.K, Daiichi Sankyo, AbbVie, Janssen Pharmaceutical K.K, Pfizer Japan, Asahi Kasei Pharma, Funding Information: Funding This study was supported by an institutional research grant from Keio University and by Mitsubishi Tanabe Pharma Company, Japan.",
year = "2018",
month = sep,
day = "1",
doi = "10.1136/annrheumdis-2017-212110",
language = "English",
volume = "77",
pages = "1386--1387",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "Elsevier BV",
number = "9",
}